Stocks and InvestingStocks and Investing
Wed, October 4, 2017
Tue, October 3, 2017
Mon, October 2, 2017
Fri, September 29, 2017
Thu, September 28, 2017
Wed, September 27, 2017
Tue, September 26, 2017
Mon, September 25, 2017
Fri, September 22, 2017
Thu, September 21, 2017

Geoff Meacham Maintained (ALNY) at Buy with Increased Target to $127 on, Sep 21st, 2017


Published on 2024-10-25 22:56:21 - WOPRAI, Geoff Meacham
  Print publication without navigation


Geoff Meacham of Barclays, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Buy with Increased Target from $105 to $127 on, Sep 21st, 2017.

Geoff has made no other calls on ALNY in the last 4 months.



There are 2 other peers that have a rating on ALNY. Out of the 2 peers that are also analyzing ALNY, 0 agree with Geoff's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Geoff


  • Christopher Marai of "Nomura" Initiated at Sell and Held Target at $56 on, Friday, September 15th, 2017
  • Do Kim of "BMO Capital" Maintained at Buy with Decreased Target to $99 on, Friday, September 8th, 2017